Health and Medicine Notices




294 NEW ZEALAND GAZETTE No. 11

Product:
Leucomax
Active Ingredient:
Molgramostim 400µg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer:
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product:
Leucomax
Active Ingredient:
Molgramostim 50µg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product:
Leucomax
Active Ingredient:
Molgramostim 700µg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Dated this 31st day of January 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go827

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Ketek
Active Ingredient:
Telithromycin 400mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer:
Aventis Pharmaceuticals Inc, Kansas City, Missouri, United States of America

Product:
Laxsol
Active Ingredient(s):
Docusate sodium 50.69mg equivalent to 50mg docusate anhydrous
Sennosides 8mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Zuellig-Pharma Limited
Manufacturer:
Sigma Pharmaceuticals Pty Limited, Croydon, Victoria, Australia

Product:
Metvix
Active Ingredient:
Methyl aminolevulinate hydrochloride 200mg/g equivalent to 160mg/g methyl aminolevulinate
Dosage Form:
Topical cream
New Zealand Sponsor:
Health Consulting Group Limited
Manufacturer:
Penn Pharmaceuticals Limited, Tredegar, Gwent, United Kingdom

Product:
Zanlan
Active Ingredient:
Cetirizine hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Agis Industries Limited, Yeruham, Israel

Dated this 31st day of January 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go826

New Zealand Public Health and Disability Act 2000

Appointments to the National Ethics Committee on Assisted Human Reproduction

Pursuant to sections 11 and 16 (3) of the New Zealand Public Health and Disability Act 2000, I appoint

Dr Beverley Lawton
Helene Leaf

as members of the National Ethics Committee on Assisted Human Reproduction for terms of 2 years commencing on the date of notification in the New Zealand Gazette.

Dated at Wellington this 28th day of January 2002.

ANNETTE KING, Minister of Health.

go820



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 11


Gazette.govt.nz PDF NZ Gazette 2002, No 11





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a Changed Medicine (continued from previous page)

🏥 Health & Social Welfare
31 January 2002
Medicines Act, Leucomax, Molgramostim, Novartis, Schering-Plough
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
31 January 2002
Medicines Act, Ketek, Telithromycin, Aventis Pharma, Laxsol, Docusate sodium, Sennosides, Metvix, Methyl aminolevulinate, Zanlan, Cetirizine hydrochloride
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Appointments to the National Ethics Committee on Assisted Human Reproduction

🏥 Health & Social Welfare
28 January 2002
Public Health and Disability Act, National Ethics Committee, Assisted Human Reproduction
  • Beverley Lawton (Dr), Appointed member of National Ethics Committee
  • Helene Leaf, Appointed member of National Ethics Committee

  • Aninette King, Minister of Health